Elevated IL-17 and TGF-β Serum Levels: A Positive Correlation between T-helper 17 Cell-Related Pro-Inflammatory Responses with Major Depressive Disorder
Depression is a mental disorder that highly associated with immune system. Therefore, this study compares the serum concentrations of IL-21, IL-17, and transforming growth factor β (TGF-β) between patients with major depressive disorder and healthy controls. Blood samples were collected from 41 pati...
Saved in:
Published in | Basic and clinical neuroscience Vol. 7; no. 2; pp. 137 - 142 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Iran
Negah Scientific Publisher
01.04.2016
Iranian Neuroscience Society Iran University of Medical Sciences |
Subjects | |
Online Access | Get full text |
ISSN | 2228-7442 2008-126X 2228-7442 |
DOI | 10.15412/J.BCN.03070207 |
Cover
Abstract | Depression is a mental disorder that highly associated with immune system. Therefore, this study compares the serum concentrations of IL-21, IL-17, and transforming growth factor β (TGF-β) between patients with major depressive disorder and healthy controls.
Blood samples were collected from 41 patients with major depressive disorder and 40 healthy age-matched controls with no history of malignancies or autoimmune disorders. The subjects were interviewed face to face according to DSM-IV diagnostic criteria. Depression score was measured using completed Beck Depression Inventory in both groups. The serum concentrations of IL-21, IL-17, and TGF-β were assessed using ELISA.
The mean score of Beck Depression score in the patient and control groups was 35.4±5.5 and 11.1±2.3. IL-17 serum concentrations in the patients and the control group were 10.03±0.6 and 7.6±0.6 pg/mL, respectively (P=0.0002). TGF-β level in the patients group was significantly higher than compare to the control group; 336.7±20.19 vs. 174.8±27.20 pg/mL, (P<0.0001). However, the level of IL-21 was not statistically different between the two groups 84.30±4.57 vs. 84.12±4.15 pg/mL (P>0.05).
Considering pro-inflammatory cytokines, current results support the association of inflammatory response and depressive disorder. So, it seems that pro-inflammatory factors profile can be used as indicator in following of depression progress and its treatment impacts. |
---|---|
AbstractList | Introduction: Depression is a mental disorder that highly associated with immune system.Therefore, this study compares the serum concentrations of IL-21, IL-17, and transforminggrowth factor β (TGF-β) between patients with major depressive disorder and healthy controls. Methods: Blood samples were collected from 41 patients with major depressive disorder and40 healthy age-matched controls with no history of malignancies or autoimmune disorders. Thesubjects were interviewed face to face according to DSM-IV diagnostic criteria. Depressionscore was measured using completed Beck Depression Inventory in both groups. The serumconcentrations of IL-21, IL-17, and TGF-β were assessed using ELISA. Results: The mean score of Beck Depression score in the patient and control groups was35.4±5.5 and 11.1±2.3. IL-17 serum concentrations in the patients and the control group were10.03±0.6 and 7.6±0.6 pg/mL, respectively (P=0.0002). TGF-β level in the patients group wassignificantly higher than compare to the control group; 336.7±20.19 vs. 174.8±27.20 pg/mL,(P<0.0001). However, the level of IL-21 was not statistically different between the two groups84.30±4.57 vs. 84.12±4.15 pg/mL (P>0.05). Conclusion: Considering pro-inflammatory cytokines, current results support the associationof inflammatory response and depressive disorder. So, it seems that pro-inflammatory factorsprofile can be used as indicator in following of depression progress and its treatment impacts. Depression is a mental disorder that highly associated with immune system. Therefore, this study compares the serum concentrations of IL-21, IL-17, and transforming growth factor β (TGF-β) between patients with major depressive disorder and healthy controls. Blood samples were collected from 41 patients with major depressive disorder and 40 healthy age-matched controls with no history of malignancies or autoimmune disorders. The subjects were interviewed face to face according to DSM-IV diagnostic criteria. Depression score was measured using completed Beck Depression Inventory in both groups. The serum concentrations of IL-21, IL-17, and TGF-β were assessed using ELISA. The mean score of Beck Depression score in the patient and control groups was 35.4±5.5 and 11.1±2.3. IL-17 serum concentrations in the patients and the control group were 10.03±0.6 and 7.6±0.6 pg/mL, respectively (P=0.0002). TGF-β level in the patients group was significantly higher than compare to the control group; 336.7±20.19 vs. 174.8±27.20 pg/mL, (P<0.0001). However, the level of IL-21 was not statistically different between the two groups 84.30±4.57 vs. 84.12±4.15 pg/mL (P>0.05). Considering pro-inflammatory cytokines, current results support the association of inflammatory response and depressive disorder. So, it seems that pro-inflammatory factors profile can be used as indicator in following of depression progress and its treatment impacts. Depression is a mental disorder that highly associated with immune system. Therefore, this study compares the serum concentrations of IL-21, IL-17, and transforming growth factor β (TGF-β) between patients with major depressive disorder and healthy controls.INTRODUCTIONDepression is a mental disorder that highly associated with immune system. Therefore, this study compares the serum concentrations of IL-21, IL-17, and transforming growth factor β (TGF-β) between patients with major depressive disorder and healthy controls.Blood samples were collected from 41 patients with major depressive disorder and 40 healthy age-matched controls with no history of malignancies or autoimmune disorders. The subjects were interviewed face to face according to DSM-IV diagnostic criteria. Depression score was measured using completed Beck Depression Inventory in both groups. The serum concentrations of IL-21, IL-17, and TGF-β were assessed using ELISA.METHODSBlood samples were collected from 41 patients with major depressive disorder and 40 healthy age-matched controls with no history of malignancies or autoimmune disorders. The subjects were interviewed face to face according to DSM-IV diagnostic criteria. Depression score was measured using completed Beck Depression Inventory in both groups. The serum concentrations of IL-21, IL-17, and TGF-β were assessed using ELISA.The mean score of Beck Depression score in the patient and control groups was 35.4±5.5 and 11.1±2.3. IL-17 serum concentrations in the patients and the control group were 10.03±0.6 and 7.6±0.6 pg/mL, respectively (P=0.0002). TGF-β level in the patients group was significantly higher than compare to the control group; 336.7±20.19 vs. 174.8±27.20 pg/mL, (P<0.0001). However, the level of IL-21 was not statistically different between the two groups 84.30±4.57 vs. 84.12±4.15 pg/mL (P>0.05).RESULTSThe mean score of Beck Depression score in the patient and control groups was 35.4±5.5 and 11.1±2.3. IL-17 serum concentrations in the patients and the control group were 10.03±0.6 and 7.6±0.6 pg/mL, respectively (P=0.0002). TGF-β level in the patients group was significantly higher than compare to the control group; 336.7±20.19 vs. 174.8±27.20 pg/mL, (P<0.0001). However, the level of IL-21 was not statistically different between the two groups 84.30±4.57 vs. 84.12±4.15 pg/mL (P>0.05).Considering pro-inflammatory cytokines, current results support the association of inflammatory response and depressive disorder. So, it seems that pro-inflammatory factors profile can be used as indicator in following of depression progress and its treatment impacts.CONCLUSIONConsidering pro-inflammatory cytokines, current results support the association of inflammatory response and depressive disorder. So, it seems that pro-inflammatory factors profile can be used as indicator in following of depression progress and its treatment impacts. Introduction: Depression is a mental disorder that highly associated with immune system. Therefore, this study compares the serum concentrations of IL-21, IL-17, and transforming growth factor β (TGF-β) between patients with major depressive disorder and healthy controls.Methods: Blood samples were collected from 41 patients with major depressive disorder and 40 healthy age-matched controls with no history of malignancies or autoimmune disorders. The subjects were interviewed face to face according to DSM-IV diagnostic criteria. Depression score was measured using completed Beck Depression Inventory in both groups. The serum concentrations of IL-21, IL-17, and TGF-β were assessed using ELISA.Results: The mean score of Beck Depression score in the patient and control groups was 35.4±5.5 and 11.1±2.3. IL-17 serum concentrations in the patients and the control group were 10.03±0.6 and 7.6±0.6 pg/mL, respectively (P=0.0002). TGF-β level in the patients group was significantly higher than compare to the control group; 336.7±20.19 vs. 174.8±27.20 pg/mL, (P<0.0001). However, the level of IL-21 was not statistically different between the two groups 84.30±4.57 vs. 84.12±4.15 pg/mL (P>0.05).Conclusion: Considering pro-inflammatory cytokines, current results support the associationof inflammatory response and depressive disorder. So, it seems that pro-inflammatory factors profile can be used as indicator in following of depression progress and its treatment impacts. |
Author | Ghanizadeh, A. Ahmadi Vasmehjani, A. Dezhkam, I. Baharlou, R. Keshtkar, M. Davami, M. Atashzar, M. |
Author_xml | – sequence: 1 givenname: M. surname: Davami fullname: Davami, M. – sequence: 2 givenname: R. surname: Baharlou fullname: Baharlou, R. – sequence: 3 givenname: A. surname: Ahmadi Vasmehjani fullname: Ahmadi Vasmehjani, A. – sequence: 4 givenname: A. surname: Ghanizadeh fullname: Ghanizadeh, A. – sequence: 5 givenname: M. surname: Keshtkar fullname: Keshtkar, M. – sequence: 6 givenname: I. surname: Dezhkam fullname: Dezhkam, I. – sequence: 7 givenname: M. surname: Atashzar fullname: Atashzar, M. |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/27303608$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kstuEzEUhkeoiJbSNTtkiQ2baX2bsYcFUkkvpApQlbC2PJ4zjSPPONiTVH0UXoMH4ZlwkrZqK-GNLfs7n46P_tfZTu97yLK3BB-SghN6dHH4efTtEDMsMMXiRbZHKZW54JzuPDrvZgcxznFaJWac41fZLhUMsxLLvez3qYOVHqBB40lOBNJ9g6bnZ_nfP-gHhGWHJrACFz-iY3Tpox3sCtDIhwBOD9b3qIbhBqBH03wGbgEBJccInMuv1kTSXgafj_vW6a7Tgw-36AriwvcRIrqxwwx91XMf0AksAsS4tp_Y6EMD4U32stUuwsHdvp_9PDudjr7kk-_n49HxJDdciiEvdNUWZVEShguDixLroqpZTUyaCDbGEEalkYCxlMaIVgLXJVRQ1BQDF9Kw_Wy89TZez9Ui2E6HW-W1VZsLH66VDoM1DhTjgkhWMqN1y2lZ1VVjZAVG6KamZSuT69PWtVjWHTQG-iFo90T69KW3M3XtV4rLijKyFny4EwT_awlxUJ2NJs1T9-CXURFRiYLz9KmEvn-Gzv0y9GlUilQVJoVMHSbq3eOOHlq5T0ACjraACT7GAO0DQrDaxExdqBQzdR-zVFE8qzB22KQhfcm6_9b9A2xi1bs |
CitedBy_id | crossref_primary_10_3389_fnbeh_2022_1006836 crossref_primary_10_1007_s10608_021_10282_w crossref_primary_10_1007_s43440_023_00548_3 crossref_primary_10_9758_cpn_2017_15_3_256 crossref_primary_10_3389_fped_2022_893815 crossref_primary_10_3390_jpm11020066 crossref_primary_10_3389_fimmu_2022_1010304 crossref_primary_10_2147_OARRR_S298393 crossref_primary_10_3390_cells12232749 crossref_primary_10_3389_fpsyt_2020_571636 crossref_primary_10_5114_aoms_178276 crossref_primary_10_1002_alr_22287 crossref_primary_10_3390_ijms23020669 crossref_primary_10_3389_fimmu_2021_699848 crossref_primary_10_1007_s00403_017_1765_9 crossref_primary_10_1007_s00406_024_01864_2 crossref_primary_10_3389_fpsyt_2022_936052 crossref_primary_10_1038_s41598_022_22744_6 crossref_primary_10_3389_fimmu_2024_1479471 crossref_primary_10_3389_fphar_2021_649144 crossref_primary_10_23736_S0392_0488_18_06112_6 crossref_primary_10_1080_1744666X_2018_1401468 crossref_primary_10_3389_fpsyt_2023_1130989 crossref_primary_10_2147_ITT_S240891 crossref_primary_10_3389_fimmu_2022_932152 crossref_primary_10_1007_s00221_019_05682_0 crossref_primary_10_1002_iid3_70092 crossref_primary_10_3389_fcimb_2023_1078984 crossref_primary_10_3390_jpm11030220 crossref_primary_10_2478_sjecr_2018_0076 crossref_primary_10_1038_s41380_024_02507_7 crossref_primary_10_1186_s13293_024_00589_0 crossref_primary_10_3389_fpubh_2022_1021309 |
ContentType | Journal Article |
Copyright | Copyright Negah Scientific Publisher 2016 Copyright© 2016 Iranian Neuroscience Society 2016 |
Copyright_xml | – notice: Copyright Negah Scientific Publisher 2016 – notice: Copyright© 2016 Iranian Neuroscience Society 2016 |
DBID | AAYXX CITATION NPM 8FE 8FH AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO GNUQQ HCIFZ LK8 M7P PHGZM PHGZT PKEHL PQEST PQGLB PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.15412/J.BCN.03070207 |
DatabaseName | CrossRef PubMed ProQuest SciTech Collection ProQuest Natural Science Collection ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One ProQuest Central Korea ProQuest Central Student SciTech Premium Collection Biological Sciences Biological Science Database ProQuest Central Premium ProQuest One Academic (New) ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef PubMed ProQuest Central Student ProQuest Biological Science Collection ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest One Academic Eastern Edition SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection Biological Science Database ProQuest SciTech Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest One Academic UKI Edition Natural Science Collection ProQuest Central Korea Biological Science Collection ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) MEDLINE - Academic |
DatabaseTitleList | PubMed MEDLINE - Academic ProQuest Central Student |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2228-7442 |
EndPage | 142 |
ExternalDocumentID | oai_doaj_org_article_34718363caaf4269b9dc89ec7adb26f8 PMC4892318 27303608 10_15412_J_BCN_03070207 |
Genre | Journal Article |
GroupedDBID | --- 5VS 8FE 8FH AAYXX ABDBF ABIVO ACPRK ACUHS ADBBV ADRAZ AFKRA ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BBNVY BCNDV BENPR BHPHI CCPQU CITATION DIK EBD EOJEC GROUPED_DOAJ HCIFZ HYE IPNFZ KQ8 LK8 M48 M7P OBODZ OK1 PGMZT PHGZM PHGZT RIG RPM M~E NPM AZQEC DWQXO GNUQQ PKEHL PQEST PQGLB PQQKQ PQUKI PRINS 7X8 5PM PUEGO |
ID | FETCH-LOGICAL-c487t-5a9f56561305c0560a59b3b1c2070ccc1328c8e0088cc7f8e4a6e9e5b20e478c3 |
IEDL.DBID | BENPR |
ISSN | 2228-7442 2008-126X |
IngestDate | Wed Aug 27 01:01:07 EDT 2025 Thu Aug 21 14:06:54 EDT 2025 Fri Jul 11 09:12:53 EDT 2025 Fri Jul 25 10:39:14 EDT 2025 Thu Jan 02 22:23:03 EST 2025 Tue Jul 01 03:23:20 EDT 2025 Thu Apr 24 22:59:36 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | Inflammatory response Transforming growth factor-beta Interleukin-17 interleukin-21 Major depressive disorder |
Language | English |
License | This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c487t-5a9f56561305c0560a59b3b1c2070ccc1328c8e0088cc7f8e4a6e9e5b20e478c3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | https://doaj.org/article/34718363caaf4269b9dc89ec7adb26f8 |
PMID | 27303608 |
PQID | 1990158269 |
PQPubID | 2046373 |
PageCount | 6 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_34718363caaf4269b9dc89ec7adb26f8 pubmedcentral_primary_oai_pubmedcentral_nih_gov_4892318 proquest_miscellaneous_1797544132 proquest_journals_1990158269 pubmed_primary_27303608 crossref_primary_10_15412_J_BCN_03070207 crossref_citationtrail_10_15412_J_BCN_03070207 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2016-04-01 |
PublicationDateYYYYMMDD | 2016-04-01 |
PublicationDate_xml | – month: 04 year: 2016 text: 2016-04-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Iran |
PublicationPlace_xml | – name: Iran – name: Tehran |
PublicationTitle | Basic and clinical neuroscience |
PublicationTitleAlternate | Basic Clin Neurosci |
PublicationYear | 2016 |
Publisher | Negah Scientific Publisher Iranian Neuroscience Society Iran University of Medical Sciences |
Publisher_xml | – name: Negah Scientific Publisher – name: Iranian Neuroscience Society – name: Iran University of Medical Sciences |
References | 20083665 - J Immunol. 2010 Feb 15;184(4):1776-83 19262136 - Cell Adh Migr. 2007 Jul-Sep;1(3):142-4 20373471 - Hum Psychopharmacol. 2010 Apr;25(3):201-15 24302954 - Psychiatry Investig. 2013 Sep;10(3):294-9 23174342 - Biol Psychiatry. 2013 Apr 1;73(7):622-30 20383173 - Cell Mol Immunol. 2010 May;7(3):164-74 18483277 - Cancer Res. 2008 May 15;68(10):3915-23 21391901 - Expert Opin Ther Targets. 2011 Jun;15(6):695-702 20452036 - Psychiatry Res. 2010 Jun 30;178(1):92-6 18317531 - Clin Dev Immunol. 2007;2007:76396 21585245 - Ann Med. 2011 Nov;43(7):503-11 17433516 - Prog Neuropsychopharmacol Biol Psychiatry. 2007 Jun 30;31(5):1044-53 12461566 - Nat Rev Immunol. 2002 Dec;2(12):933-44 21684012 - J Affect Disord. 2011 Nov;134(1-3):217-25 21787348 - Biochem Soc Trans. 2011 Aug;39(4):1061-6 14631599 - Psychiatr Pol. 2003 Sep-Oct;37(5):787-98 9472719 - Life Sci. 1998;62(7):583-606 9770242 - Prog Neurobiol. 1998 Oct;56(3):307-40 17360153 - Brain Behav Immun. 2007 May;21(4):374-83 23172104 - Neuroimmunomodulation. 2013;20(1):39-50 17569825 - Science. 2007 Jul 13;317(5835):256-60 24257035 - Toxins (Basel). 2013 Nov 19;5(11):2227-40 16782542 - Int Immunopharmacol. 2006 Aug;6(8):1298-304 16200070 - Nat Immunol. 2005 Nov;6(11):1123-32 15694227 - Prog Neuropsychopharmacol Biol Psychiatry. 2005 Feb;29(2):201-17 23527713 - Int J Immunopathol Pharmacol. 2013 Jan-Mar;26(1):107-15 22533549 - Inflamm Allergy Drug Targets. 2012 Aug 1;11(4):313-9 17919797 - Prog Neuropsychopharmacol Biol Psychiatry. 2008 Feb 15;32(2):356-61 |
References_xml | – reference: 9472719 - Life Sci. 1998;62(7):583-606 – reference: 18317531 - Clin Dev Immunol. 2007;2007:76396 – reference: 20083665 - J Immunol. 2010 Feb 15;184(4):1776-83 – reference: 23172104 - Neuroimmunomodulation. 2013;20(1):39-50 – reference: 21787348 - Biochem Soc Trans. 2011 Aug;39(4):1061-6 – reference: 20383173 - Cell Mol Immunol. 2010 May;7(3):164-74 – reference: 21684012 - J Affect Disord. 2011 Nov;134(1-3):217-25 – reference: 17360153 - Brain Behav Immun. 2007 May;21(4):374-83 – reference: 9770242 - Prog Neurobiol. 1998 Oct;56(3):307-40 – reference: 12461566 - Nat Rev Immunol. 2002 Dec;2(12):933-44 – reference: 15694227 - Prog Neuropsychopharmacol Biol Psychiatry. 2005 Feb;29(2):201-17 – reference: 16200070 - Nat Immunol. 2005 Nov;6(11):1123-32 – reference: 19262136 - Cell Adh Migr. 2007 Jul-Sep;1(3):142-4 – reference: 16782542 - Int Immunopharmacol. 2006 Aug;6(8):1298-304 – reference: 17919797 - Prog Neuropsychopharmacol Biol Psychiatry. 2008 Feb 15;32(2):356-61 – reference: 20452036 - Psychiatry Res. 2010 Jun 30;178(1):92-6 – reference: 24302954 - Psychiatry Investig. 2013 Sep;10(3):294-9 – reference: 23174342 - Biol Psychiatry. 2013 Apr 1;73(7):622-30 – reference: 14631599 - Psychiatr Pol. 2003 Sep-Oct;37(5):787-98 – reference: 17569825 - Science. 2007 Jul 13;317(5835):256-60 – reference: 22533549 - Inflamm Allergy Drug Targets. 2012 Aug 1;11(4):313-9 – reference: 21391901 - Expert Opin Ther Targets. 2011 Jun;15(6):695-702 – reference: 18483277 - Cancer Res. 2008 May 15;68(10):3915-23 – reference: 20373471 - Hum Psychopharmacol. 2010 Apr;25(3):201-15 – reference: 17433516 - Prog Neuropsychopharmacol Biol Psychiatry. 2007 Jun 30;31(5):1044-53 – reference: 24257035 - Toxins (Basel). 2013 Nov 19;5(11):2227-40 – reference: 21585245 - Ann Med. 2011 Nov;43(7):503-11 – reference: 23527713 - Int J Immunopathol Pharmacol. 2013 Jan-Mar;26(1):107-15 |
SSID | ssj0000603440 ssib044731253 |
Score | 2.3632398 |
Snippet | Depression is a mental disorder that highly associated with immune system. Therefore, this study compares the serum concentrations of IL-21, IL-17, and... Introduction: Depression is a mental disorder that highly associated with immune system. Therefore, this study compares the serum concentrations of IL-21,... Introduction: Depression is a mental disorder that highly associated with immune system.Therefore, this study compares the serum concentrations of IL-21,... |
SourceID | doaj pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 137 |
SubjectTerms | Autoimmune diseases Enzyme-linked immunosorbent assay Immune system Inflammatory response Interleukin 17 Interleukin 21 Major depressive disorder Mental depression Research Papers Serum levels Transforming growth factor-b Transforming growth factor-beta |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NbtQwELZQD4gLovwGCjISBy7eJnF-bG7t0qVddasKbaW9RfbEUUFpttqfvktfgwfhmZhxstEuAnHhmjhWMjP2fOP5MsPYB_QZMoosiExXlSDIIIzMjQAHcVlp3DQNBYqTi-z0KhnP0tlWqy_ihLXlgVvBHUraPWUmwZiKfru0ugSlHeSmtHFW-d98Qx1uBVNoSUmSS_Tcsj9tCTMqbUcHLj7fH8XZrKvzkyZRfDgeHA8vBt7-Y2osu-WifCX_P8HP31mUW25p9IQ97vAkP2q_Y589cM1T9nDSZcyfsfuT2t0hniz52bmIcm6akk-_jMTPHxy3ifUNPyfW0PITP-KXnr915_iQOna0HDne8bj4VFy7-tYtOM4xdHUtPIsOp71czMVZU6Fh3fiEPf_asm7dktMZL5-Y7_MF_9wRbnH2Tb3P5-xqdDIdnoquHYMAjGpWIjW6IviHXi8FxE2hSbWVNgIUWQgAGNcqUA7lqwDySrnEZE671MahS3IF8gXba-aNe8V4aWUMOpdGJxHK3yppVaogjpVB-KmrgA02Giigq1VOLTPqgmIWUlkxLlBlxUZlAfvYP3Dblun4-9BjUmk_jOpr-wtodUVndcW_rC5gBxuDKLpFvywiyjGmGK_pgL3vb-NypRyMadx8jWNyTSUHUVYBe9naT_8miCQRT4Q4eb5jWTuvunun-XbtS4InioC6ev0_vu0Ne4SoMGvpSQdsb7VYu7eIvFb2nV9kvwAApCeW priority: 102 providerName: Directory of Open Access Journals – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1tb9MwELbQkBBfEO8EBjISH_ji0sR5sZEQ2srKVq3ThFqp3yLbcTZQloy0neCn8Df4Ifwm7pyXUVT42rgn6-6ce8735I6QVxAzuO9rw2KZ5wwhA1M8UcxYE2S5hJemwkRxehIfzsPJIlpcjwNqFbjcmtrhPKl5XQy-ff3-Hg78Oze9J_SDN5PB_uhk4Nw3wC_Lb7piEfL4rrF-GCYcgjnvL2CGMXa7wzsYRwHwg3jRtv7ZInMjarnm_tsQ6d_Eyj8i1fguudNCTLrX-MQ9csOW98mtaVtEf0B-HBT2CiBmRo-OmZ9QVWZ09nHMfv2k8OZYX9BjJBIt39I9euooXVeWjnCIR0Oboy21i87YuS0ubU1BxsgWBXPEOhB7WlfsqMzB1y5cDZ9-aoi4dknx2pdO1Zeqph9aDi5I71qAPiTz8cFsdMjaCQ3MQKKzYpGSOSJC0HZkAEoNVSQ1174BlQ2NMZDqCiMs6FcYk-TChiq20kY6GNowEYY_IjtlVdonhGaaB0YmXMnQB_1rwbWIhAkCoQCRytwjg84CqWnbl-MUjSLFNAZNlk5SMFnamcwjr_s_XDadO_69dB9N2i_Dltvuh6o-S9sTnHIM4zzmRqkcv__VMjNCWpOoTAdxLjyy2zlE2rlx6mPZMYIUTnrkZf8YTjCWZVRpqzWsSSR2IQRdeeRx4z_9TgBcAsQYgvBkw7M2trr5pPx87rqEhwKxu3j6_209I7cBAsYNF2mX7KzqtX0OMGulX7jj8xvy9iEb priority: 102 providerName: Scholars Portal |
Title | Elevated IL-17 and TGF-β Serum Levels: A Positive Correlation between T-helper 17 Cell-Related Pro-Inflammatory Responses with Major Depressive Disorder |
URI | https://www.ncbi.nlm.nih.gov/pubmed/27303608 https://www.proquest.com/docview/1990158269 https://www.proquest.com/docview/1797544132 https://pubmed.ncbi.nlm.nih.gov/PMC4892318 https://doaj.org/article/34718363caaf4269b9dc89ec7adb26f8 |
Volume | 7 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NjtMwELaWVkJcVvzTZamMxIGLu0mcHxsJobbbslttq2rVlXqLHMdhQd2k9GePvAevwYPwTMw4Sdki4JJD4liWZzzzefx5hpA34DO46yaahTLLGEIGpnikmDbaSzMJRlPhRnE8Cc-u_NE8mB-QSX0XBmmVtU20hjotNMbIT1w8wAkADMsPy68Mq0bh6WpdQkNVpRXS9zbF2D3SBJMcOA3S7A0m08taw3w_4vCe76IwTogp7zAQY3kArhfOq_w_ge96J6NOrz_p2HXhYcHZO67LZvj_Gyz9k115x10NH5LDCmfSbqkYj8iByR-T--PqJP0J-T5YmFvAmSk9v2BuRFWe0tnHIfv5g4L52N7QC2QTrd_RLp1aXtetoX2s5FFy52jF76Izdm0WS7Oi0EffLBbMsuug2-mqYOd5Bgp3Yw_y6WXJxjVrirFfOlZfihU9rYi40HudB_QpuRoOZv0zVpVpYBp2OxsWKJkhLARvGGjAU44KZMITV8OUOVpr2O8KLQzMr9A6yoTxVWikCRLPMX4kNH9GGnmRmxeEpgn3tIy4kr4L858InohAaM8TCmCpzFqkU0sg1lUOcyylsYhxL4Mii0cxiCyuRdYib3c_LMv0Hf9u2kOR7pph3m37olh9iqtlHHP05TzkWqkMLwEnMtVCGh2pNPHCTLTIca0QcWUM1vFv1W2R17vPsIzxbEblpthCm0hiKkKYqxZ5XurPbiSAMAFnONB5tKdZe0Pd_5J_vrapwn2BAF4c_X9YL8kDwIFhSUg6Jo3NamteAdbaJG3S7PZOe8N2tZDaNmYBz7Ev8Plt8AubIimN |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3dbtMwFLZGJwE3iH8KA4wEEjfumjg_NtKE1q6l7dqqmjqpd8FxHAbqktKfIR6F1-ABeASeiXNSp6wIuNtt4hxZOT_-jv35HEJewprBHSfWLJBpyhAyMMVDxbTRbpJKCJoKE8XBMOicer2JP9khP8q7MEirLGNiEaiTXOMe-b6DBzg-gGH5dvaZYdcoPF0tW2go21ohOShKjNmLHcfm6xdI4RYH3SPQ9yvXbbfGzQ6zXQaYBrC-ZL6SKaIaCOa-BjhQV76MeexoF7xBaw3pmtDCwFoptA5TYTwVGGn82K0bLxSag9xrZNfDDZQK2W20hqOT0qI9L-SAIPhm16ceYIk93PgpeAeOG0xsvSHfc9z9Xq3RHNYKP3Sxwe2lpbLoKPA3GPwnm_PS8ti-TW5ZXEsP14Z4h-yY7C65PrAn9_fIt9bUXACuTWi3z5yQqiyh43dt9vM7hXC1Oqd9ZC8t3tBDOip4ZBeGNrFzyJqrRy2fjI7ZmZnOzJyCjKaZTlnB5gOxo3nOulkKBn5eEAfoyZr9axYU95rpQH3K5_TIEn9Bell39D45vRKFPSCVLM_MI0KTmLtahlxJz4H_HwseC19o1xUKYLBMq6RWaiDStmY6tu6YRpg7ocqiXgQqi0qVVcnrzQezdbmQfw9toEo3w7DOd_Egn3-IbNiIOGIHHnCtVIqXjmOZaCGNDlUSu0EqqmSvNIjIBp9F9NtVquTF5jWEDTwLUpnJVzAmlFj6EP5VlTxc289mJoBoAdfUQXi4ZVlbU91-k308K0qTewITBvH4_9N6Tm50xoN-1O8Oj5-Qm4BBgzUZao9UlvOVeQo4bxk_s85Eyfur9t9fVHxhCg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Elevated+IL-17+and+TGF-%CE%B2+Serum+Levels%3A+A+Positive+Correlation+between+T-helper+17+Cell-Related+Pro-Inflammatory+Responses+with+Major+Depressive+Disorder&rft.jtitle=Basic+and+clinical+neuroscience&rft.au=Davami%2C+Mohammad+Hasan&rft.au=Baharlou%2C+Rasoul&rft.au=Abbas+Ahmadi+Vasmehjani&rft.au=Ghanizadeh%2C+Ahmad&rft.date=2016-04-01&rft.pub=Negah+Scientific+Publisher&rft.issn=2008-126X&rft.eissn=2228-7442&rft.volume=7&rft.issue=2&rft.spage=137&rft_id=info:doi/10.15412%2FJ.BCN.03070207 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2228-7442&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2228-7442&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2228-7442&client=summon |